Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigation of the carbonic anhydrase inhibitory activity of benzenesulfonamides incorporating substituted fused‐pyrimidine tails
Heba T. Abdel‐Mohsen, Andrea Petreni, Claudiu T. Supuran
Archiv der Pharmazie (2022) Vol. 355, Iss. 11
Closed Access | Times Cited: 14

Showing 14 citing articles:

Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 9
Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity
Heba T. Abdel‐Mohsen, Yasmin M. Syam, Mahmoud S. Abd El‐Ghany, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 8
Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies
Yasmin M. Syam, Somaia S. Abd El‐Karim, Heba T. Abdel‐Mohsen
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 7
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 17
Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies
Rasha M. Hassan, Islam H. Ali, Ahmed M. El Kerdawy, et al.
Bioorganic Chemistry (2024) Vol. 152, pp. 107728-107728
Closed Access | Times Cited: 6
Novel 5,6-dichlorobenzimidazole derivatives as dual BRAFWT and BRAFV600E inhibitors: design, synthesis, anti-cancer activity and molecular dynamics simulations
Ahmed Temirak, Ahmed M. El Kerdawy, Amira M. Nageeb, et al.
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Diphenyl urea‐benzylidene acetohydrazide hybrids as fibroblast growth factor receptor 1 inhibitors and anticancer agents
Heba T. Abdel‐Mohsen, Amira M. Nageeb, Iman A. Y. Ghannam
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access | Times Cited: 4
Discovery of novel diaryl urea-oxindole hybrids as BRAF kinase inhibitors targeting BRAF and KRAS mutant cancers
Iman A. Y. Ghannam, Ahmed M. El Kerdawy, Marwa M. Mounier, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107848-107848
Closed Access | Times Cited: 4
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review
Anjaneyulu Bendi, Taruna, Rajni Rajni, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 7
Closed Access | Times Cited: 3
Benzimidazole–dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions
Heba T. Abdel‐Mohsen, Amira M. Nageeb
RSC Advances (2024) Vol. 14, Iss. 39, pp. 28889-28903
Open Access | Times Cited: 3
The anticancer therapeutic potential of pyrimidine–sulfonamide hybrids
Peng Zhang, Congcong Shi, Tongbao Dong, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 9, pp. 905-924
Closed Access | Times Cited: 2
Oxindole–benzothiazole hybrids as CDK2 inhibitors and anticancer agents: design, synthesis and biological evaluation
Heba T. Abdel‐Mohsen
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Discovery of novel thioquinazoline-N-aryl-acetamide/N-arylacetohydrazide hybrids as anti-SARS-CoV-2 agents: Synthesis, in vitro biological evaluation, and molecular docking studies
Heba T. Abdel‐Mohsen, Mohamed A. Omar, Omnia Kutkat, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134690-134690
Open Access | Times Cited: 8
Novel benzenesulfonamide‐thiouracil conjugates with a flexible N‐ethyl acetamide linker as selective CA IX and CA XII inhibitors
Heba T. Abdel‐Mohsen, Ahmed M. El Kerdawy, Andrea Petreni, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Closed Access | Times Cited: 5
Page 1

Scroll to top